Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
Background Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarkers...
Main Authors: | Yun Gao, Ziyi Dai, Chenxi Yang, Ding Wang, Zhenying Guo, Weimin Mao, Zhongjian Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12568.pdf |
Similar Items
-
A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
by: Zhongjian Chen, et al.
Published: (2021-11-01) -
GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma
by: Ding Wang, et al.
Published: (2023-05-01) -
Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
by: Na Li, et al.
Published: (2021-07-01) -
Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
by: Zhenying Guo, et al.
Published: (2021-12-01) -
Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
by: Roberta Affatato, et al.
Published: (2020-12-01)